BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8976389)

  • 1. 3p21 is a recurrent treatment-related breakpoint in myelodysplastic syndrome and acute myeloid leukemia.
    Shi G; Weh HJ; Martensen S; Seeger D; Hossfeld DK
    Cytogenet Cell Genet; 1996; 74(4):295-9. PubMed ID: 8976389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia.
    Pedersen-Bjergaard J; Pedersen M; Roulston D; Philip P
    Blood; 1995 Nov; 86(9):3542-52. PubMed ID: 7579462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
    Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
    Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy-related myelodysplastic syndrome and acute myeloid leukemia with 17p deletion. A report on 25 cases.
    Merlat A; Lai JL; Sterkers Y; Demory JL; Bauters F; Preudhomme C; Fenaux P
    Leukemia; 1999 Feb; 13(2):250-7. PubMed ID: 10025899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
    Fischer K; Fröhling S; Scherer SW; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui LC; Lichter P; Döhner H
    Blood; 1997 Mar; 89(6):2036-41. PubMed ID: 9058725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.
    Smith SM; Le Beau MM; Huo D; Karrison T; Sobecks RM; Anastasi J; Vardiman JW; Rowley JD; Larson RA
    Blood; 2003 Jul; 102(1):43-52. PubMed ID: 12623843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
    Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
    Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53.
    Wang P; Spielberger RT; Thangavelu M; Zhao N; Davis EM; Iannantuoni K; Larson RA; Le Beau MM
    Genes Chromosomes Cancer; 1997 Nov; 20(3):282-91. PubMed ID: 9365836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Abnormalities of chromosome 17 in myeloid malignancies with complex chromosomal abnormalities].
    Zhu Y; Xu W; Liu Q; Pan J; Qiu H; Wang R; Qiao C; Jiang Y; Zhang S; Fan L; Zhang J; Shen Y; Xue Y; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):579-82. PubMed ID: 18841577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis.
    Christiansen DH; Andersen MK; Pedersen-Bjergaard J
    J Clin Oncol; 2001 Mar; 19(5):1405-13. PubMed ID: 11230485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome.
    Nishiyama M; Arai Y; Tsunematsu Y; Kobayashi H; Asami K; Yabe M; Kato S; Oda M; Eguchi H; Ohki M; Kaneko Y
    Genes Chromosomes Cancer; 1999 Nov; 26(3):215-20. PubMed ID: 10502319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: cancer and leukemia group B 8461.
    Walker A; Mrózek K; Kohlschmidt J; Rao KW; Pettenati MJ; Sterling LJ; Marcucci G; Carroll AJ; Bloomfield CD;
    Genes Chromosomes Cancer; 2013 Apr; 52(4):385-401. PubMed ID: 23225546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangements.
    Andersen MK; Johansson B; Larsen SO; Pedersen-Bjergaard J
    Haematologica; 1998 Jun; 83(6):483-8. PubMed ID: 9676019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations.
    Caramazza D; Hussein K; Siragusa S; Pardanani A; Knudson RA; Ketterling RP; Tefferi A
    Eur J Haematol; 2010 Mar; 84(3):191-200. PubMed ID: 20002154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aberrations of chromosome 5 in myeloid malignancies with complex chromosome abnormalities].
    Liu Q; Xu W; Zhu Y; Fan L; Qiu HR; Wang R; Qiao C; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1257-60. PubMed ID: 19099622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.
    Lin P; Medeiros LJ; Yin CC; Abruzzo LV
    Cancer Genet Cytogenet; 2006 Apr; 166(1):82-5. PubMed ID: 16616115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia.
    Rubin CM; Larson RA; Anastasi J; Winter JN; Thangavelu M; Vardiman JW; Rowley JD; Le Beau MM
    Blood; 1990 Dec; 76(12):2594-8. PubMed ID: 2265251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocations between the long arms of chromosomes 1 and 5 in hematologic malignancies are strongly associated with neoplasms of the myeloid lineages.
    Johansson B; Brøndum-Nielsen K; Billström R; Schiødt I; Mitelman F
    Cancer Genet Cytogenet; 1997 Dec; 99(2):97-101. PubMed ID: 9398862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
    Swolin B; Rödjer S; Westin J
    Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.